Close

BIO Statement Regarding Commercial Development of Pluripotent Stem Cells

To the Subcommittee on Labor, Health and Human Services, Education of the Senate Appropriations Committee

BIO Urges President's Bioethics Advisory Panel To Consider Issues Raised By Stem Cell Research

Carl B Feldbaum, president of BIO, today issued the following statement on the need for national discussion based on the ethical implications of recent research breakthroughs involving primordial human stem cells...

BIO CEO & Investor Conference Presentations Target Specific Diseases, Therapies

...

Biotech Reporters: MARK YOUR CALENDAR NOW!

...

Grampsas Wins National Biotech Award

...

BIO Supports Capital Gains Incentive Bill Introduced by Rep. Dunn

...

Biotech Industry Responds To Stock Market Fluctuations

...

Rowett Research Institute, Greenburn Road, Bucksburn, Aberdeen AB21 9SB, GENETICALLY MODIFIED FOODS

...

BIO Welcomes Verification of Dolly's Cloning, Stands by Ban on Human Cloning

BIO is not surprised to learn that the Roslin Institute has verified the origins of Dolly the sheep as a product of cloning...

Seattle Selected For Biotech Meeting

...